Vaccine development and technology for SARS‐CoV‐2: Current insight

Severe acute respiratory syndrome coronavirus 2 is associated with a severe respiratory disease in China, that rapidly spread across continents. Since the beginning of the pandemic, available data suggested the asymptomatic transmission and patients were treated with specific drugs with efficacy and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2022-03, Vol.94 (3), p.878-896
Hauptverfasser:	Cattel, Luigi, Giordano, Susanna, Traina, Sara, Lupia, Tommaso, Corcione, Silvia, Angelone, Lorenzo, La Valle, Giovanni, De Rosa, Francesco G., Cattel, Francesco
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronaviruses COVID-19 - prevention & control COVID-19 Vaccines Cytoplasm Deoxyribonucleic acid DNA DNA vaccines Encapsulation Genetic engineering Humans Immunogenicity lipid nanoparticles Lipids Logistics Medical innovations Molecular biology mRNA Nanotechnology pandemic Pandemics Pharmaceuticals pneumonia Respiratory diseases Review Reviews Ribosomes Safety SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Technology vaccine Vaccine Development Vaccines Vectors (Biology) Viral diseases viral vector Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!